ArticleCommunications biology2022
Commercialized artemisinin derivatives combined with colistin protect against critical Gram-negative bacterial infection.
Yonglin Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it